How Trump loyalist Heidi Overton became the president’s pick to run the FDA

AI justification

Nomination carries risk of weakened health safeguards. | While the appointment could improve health oversight, significant concerns about industry influence and weakened safeguards tilt the overall ethical balance toward negative.